Treatments of other bladder disorders are also covered by the patent, including glycosaminoglycan ("GAG") deficient forms of cystitis or GAG-deficiency, such as, accompanying chronic urinary tract infection, radiation-
US Patent 8,859,530 covers co-administration of steroids and zoledronic acid to prevent and treat osteoarthritis. Formerly known as Voltarra Pharmaceuticals, Levolta’s patent claims methods for treating osteoarthritis by
Ninad Deshpanday, President of R&D at Kemwell said, "With this investment, we are bringing our customers a new service from our US facility. We will offer our clients
In addition to significantly strengthening the company’s balance sheet, Relmada’s CEO, Sergio Traversa, says the cash will help with its ambitious development strategy, "These funds enhance our flexibility
Specifically designed as a supplement for biological drug production, including biosimiliars, EX-CELL Glycosylation Adjust (Gal+) allows users to easily achieve desired N-linked glycosylation by increasing the galactose site
This is the first time in the current Ebola outbreak that EMA has given ‘rapid scientific advice’ using an accelerated procedure. EMA established this procedure to contribute to
The approval, issued in September 2014, allows Plandaí to grow cannabis in conjunction with the University, for medical research, which will be undertaken by students and scientists from
This financing was co-led by three new investors including AJU IB Investment Co., Ltd. and two undisclosed private investment groups. The round also includes full participation by all
XmAb5871 is a first-in-class monoclonal antibody containing Xencor’s proprietary immune inhibitor XmAb Fc domain that targets Fc?RIIb to inhibit B-cell function. XmAb5871 is currently in a Phase 1b/2a
This patent, along with prior patents issued to Curis, further strengthens the Company’s intellectual property portfolio of compounds including CUDC-907 that inhibit HDAC and PI3K enzymes in a
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.